Stephanie Gaillard, MD, PhD
Medical Oncology
Highlights
Johns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Stephanie Gaillard
Professional Titles
- Director of Gynecologic Cancer Trials
- Co-Director of Development Therapeutics/Phase I Clinical Trials Program
Primary Academic Title
Associate Professor of Oncology
Background
Stéphanie Gaillard is a medical oncologist who specializes in the treatment of gynecologic malignancies. She recently joined the faculty of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and is their Director of Gynecologic Cancer Trials. Dr. Gaillard earned her medical degree and doctoral degree in cancer biology from Duke University. Following medical school, she underwent residency training in Internal Medicine and fellowship training in Medical Oncology at the Johns Hopkins School of Medicine. Dr. Gaillard’s research focuses on the development of clinical trials aimed at improving outcomes by incorporating promising new biologic, targeted, and immune therapies into standard treatment regimens. Her translational research program focuses on understanding the immune environment associated with gynecologic cancers and mechanisms of resistance to current therapies.
Centers and Institutes
Additional Academic Titles
Associate Professor of Gynecology and Obstetrics
Selected Publications
Gaillard S, Oaknin A, Ray-Coquard I, Vergote I, Scambia G, Colombo N, Fernandez C, Alfaro V, Kahatt C, Nieto A, Zeaiter A, Aracil M, Vidal L, Pardo-Burdalo B, Papai Z, Kristeleit R, O'Malley DM, Benjamin I, Pautier P, Lorusso D. Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL). Gynecol Oncol. 2021 Nov; 163 (2) :237-245 . doi: 10.1016/j.ygyno.2021.08.032. Epub 2021 Sep 11. PubMed PMID: 34521554
Gaillard SL, Andreano KJ, Gay LM, Steiner M, Jorgensen MS, Davidson BA, Havrilesky LJ, Alvarez Secord A, Valea FA, Colon-Otero G, Zajchowski DA, Chang CY, McDonnell DP, Berchuck A, Elvin JA. Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies. Gynecol Oncol. 2019 Jul; 154 (1) :199-206 . doi: 10.1016/j.ygyno.2019.04.010. Epub 2019 Apr 13. PubMed PMID: 30987772
Gaillard SL, Zahurak M, Sharma A, Durham JN, Reiss KA, Sartorius-Mergenthaler S, Downs M, Anders NM, Ahuja N, Rudek MA, Azad N. A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors. Cancer. 2019 Aug 15; 125 (16) :2837-2845 . doi: 10.1002/cncr.32138. Epub 2019 Apr 23. PubMed PMID: 31012962 ; PubMed Central PMCID: PMC6663621
Asaka S, Yen TT, Wang TL, Shih IM, Gaillard S. T cell-inflamed phenotype and increased Foxp3 expression in infiltrating T-cells of mismatch-repair deficient endometrial cancers. Mod Pathol. 2019 Apr; 32 (4) :576-584. doi: 10.1038/s41379-018-0172-x. Epub 2018 Nov 6. PubMed PMID: 30401949 ; PubMed Central PMCID: PMC8201475.
Wethington SL, Armstrong DK, Gaillard SL. Vulnerable Older Adults With Ovarian Cancer-Time to Stop Undertreating. JAMA Oncol. 2021 Jun 1; 7 (6) :831-833 . doi: 10.1001/jamaoncol.2021.0468. PubMed PMID: 33885717
Locations
- Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
- 10803 Falls Road, Pavilion III STE 1500, Lutherville, MD 21093
- phone: 410-583-2970
- fax: 410-583-2980
- Skip Viragh Outpatient Cancer Center
- 201 North Broadway Street, Viragh BLDG 10th FL, Baltimore, MD 21287
- phone: 410-955-8964
- fax: 410-367-2194
Expertise
Education
Johns Hopkins University School of Medicine
Fellowship, Hematology and Oncology, 2012Johns Hopkins University School of Medicine
Residency, Internal Medicine, 2009Duke University School of Medicine
Medical Education, MD, 2006Duke University School of Medicine
Graduate School, Molecular Biology, PhD, 2005Board Certifications
Medical Oncology
American Board of Internal Medicine, 2011Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Humana
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- UnitedHealthcare
- Veteran Affairs Community Care Network (Optum-VACCN)
Ratings & Reviews
4.9 out of 5
60 ratings, 22 reviewsThe Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
- 5 out of 5 starsReviewed on 1/28/2025
Clear, helpful 2nd opinion
- 5 out of 5 starsReviewed on 1/21/2025
It's always a pleasure to meet with Dr. Gaillard. She's an amazing doctor & person.
- 5 out of 5 starsReviewed on 1/14/2025
This was my first visit with Dr Gaillard, and I was very impressed with her thoroughness in reviewing my case, her ability to explain options clearly and answer all of my questions. She never made me feel rushed, and her compassion was quite evident. I left her office with hope.
- 4 out of 5 starsReviewed on 11/6/2024
Very patient
- 5 out of 5 starsReviewed on 10/30/2024
Enjoyed the visit. She is very knowledgeable and gave me good advice.
- 5 out of 5 starsReviewed on 10/23/2024
Very thorough and professional
- 5 out of 5 starsReviewed on 10/17/2024
My visits with Dr. Gaillard are a pleasure. She talks me through any concerns. She is very clear in direction & alleviating any anxiety.
- 5 out of 5 starsReviewed on 10/10/2024
Dr. Gaillard was very thorough and explained in clear, concise detail the anticipated path forward in treating my disease. She is excellent.
- 4 out of 5 starsReviewed on 10/9/2024
The Dr volunteered information answering questions before asked. Very open to discussing information and details. She gave me o formation I could not get from others in a way I could understand.
- 5 out of 5 starsReviewed on 10/9/2024
Great experience
- 5 out of 5 starsReviewed on 7/31/2024
Very knowledgeable and pleasant
- 5 out of 5 starsReviewed on 7/31/2024
Excellent and very courteous
- 5 out of 5 starsReviewed on 7/18/2024
Dr. Gaillard is an excellent physician. I'm always very impressed with her level of care. She listens deeply & immediately provides reassurance in conversation or follow ups which can provide further understanding in direction of care.
- 5 out of 5 starsReviewed on 7/17/2024
Dr. Gaillard is extremely knowledgeable, competent and compassionate and has given me the best possible care during my cancer journey. She is the consummate professional and I feel that I owe a good deal of my current remission to her and [Staff]. I couldn't be happier with my experiences with both Dr. Gaillard and [Staff].
- 5 out of 5 starsReviewed on 7/3/2024
Excellent and approachable doctor. Very upbeat and detail oriented.
- 5 out of 5 starsReviewed on 6/5/2024
Great
- 5 out of 5 starsReviewed on 5/15/2024
Hopefully I can get into the trial.
- 5 out of 5 starsReviewed on 5/9/2024
She has tried to provide me with the care for my cancer.
- 5 out of 5 starsReviewed on 5/1/2024
Excellent communicator..very knowledgeable...pleasant
- 5 out of 5 starsReviewed on 4/17/2024
My comment is about being notified about my appointment by email. I would rather have a phone call, because the date that was picked did not work for me. No problem when I called to change it. Phone call has that personal feeling.
- 5 out of 5 starsReviewed on 4/10/2024
This vist was foe a second opinion only.
- 5 out of 5 starsReviewed on 4/3/2024
Very nice person, very explanatory and very polite